130 related articles for article (PubMed ID: 8623483)
1. Pharmacokinetics of rapamycin.
Yatscoff RW
Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.
Trepanier DJ; Gallant H; Legatt DF; Yatscoff RW
Clin Biochem; 1998 Jul; 31(5):345-51. PubMed ID: 9721433
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of rapamycin: single-dose studies in the rabbit.
Honcharik N; Fryer J; Yatscoff R
Ther Drug Monit; 1992 Dec; 14(6):475-8. PubMed ID: 1485369
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
Yatscoff RW; LeGatt DF; Kneteman NM
Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Johnson EM; Zimmerman J; Duderstadt K; Chambers J; Sorenson AL; Granger DK; Almond PS; Fryer Jp; Leventhal JR; Scarola J; Matas AJ; Canafax DM
Transplant Proc; 1996 Apr; 28(2):987. PubMed ID: 8623490
[No Abstract] [Full Text] [Related]
7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
[No Abstract] [Full Text] [Related]
9. Sirolimus, a new, potent immunosuppressive agent.
Kelly PA; Gruber SA; Behbod F; Kahan BD
Pharmacotherapy; 1997; 17(6):1148-56. PubMed ID: 9399599
[TBL] [Abstract][Full Text] [Related]
10. Role of therapeutic drug monitoring of rapamycin.
Kahan BD; Napoli KL
Transplant Proc; 1998 Aug; 30(5):2189-91. PubMed ID: 9723436
[No Abstract] [Full Text] [Related]
11. Population pharmacokinetics of sirolimus in kidney transplant patients.
Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
[TBL] [Abstract][Full Text] [Related]
12. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
13. Species differences in sirolimus stability in humans, rabbits, and rats.
Ferron GM; Jusko WJ
Drug Metab Dispos; 1998 Jan; 26(1):83-4. PubMed ID: 9443858
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus.
MacDonald A; Scarola J; Burke JT; Zimmerman JJ
Clin Ther; 2000; 22 Suppl B():B101-121. PubMed ID: 10823378
[TBL] [Abstract][Full Text] [Related]
15. [Rapamycin: a new immunosuppressive agent capable of inhibiting chronic rejection?].
Viklický O; Matl I
Cas Lek Cesk; 2001 Jan; 140(1):22-5. PubMed ID: 11242980
[TBL] [Abstract][Full Text] [Related]
16. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
[TBL] [Abstract][Full Text] [Related]
17. Prospects for personalized immunosuppression: pharmacologic tools--a review.
Del Tacca M
Transplant Proc; 2004 Apr; 36(3):687-9. PubMed ID: 15110631
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
[TBL] [Abstract][Full Text] [Related]
19. Brequinar sodium.
Cramer DV
Transplant Proc; 1996 Apr; 28(2):960-3. PubMed ID: 8623481
[TBL] [Abstract][Full Text] [Related]
20. Everolimus in clinical practice--renal transplantation.
Pascual J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
